RA Capital Management Q1 2020

RA Capital Management holdings Q1 2020
Name ValueChangeSharesChangeWeightingChange
ASCENDIS PHARMA A Ssponsored adr$553,473
-4.94%
4,914,955
17.43%
17.48%
-0.98%
RA PHARMACEUTICALS INC$233,245
2.30%
4,858,2600.00%7.37%
6.57%
CHEMOCENTRYX INC$167,828
32.63%
4,176,910
30.55%
5.30%
38.16%
ARVINAS INC$148,017
-1.92%
3,672,8720.00%4.68%
2.17%
ZOGENIX INC$130,464
10.70%
5,275,538
133.35%
4.12%
15.32%
AXSOME THERAPEUTICS INC$112,018
194.65%
1,904,094
417.68%
3.54%
206.94%
EIDOS THERAPEUTICS INC$105,949
-14.64%
2,162,6710.00%3.35%
-11.08%
TG THERAPEUTICS INC$102,212
-6.80%
10,387,411
5.13%
3.23%
-2.92%
SATSUMA PHARMACEUTICALS INC$100,754
9.35%
4,681,8580.00%3.18%
13.91%
ALECTOR INC$99,593
478.02%
4,127,348
312.73%
3.15%
502.12%
PHATHOM PHARMACEUTICALS INC$95,725
-15.71%
3,707,408
1.66%
3.02%
-12.19%
KALA PHARMACEUTICALS INC$95,588
470.91%
10,874,613
139.66%
3.02%
494.72%
RHYTHM PHARMACEUTICALS INC$82,528
-33.71%
5,422,3120.00%2.61%
-30.95%
89BIO INC$79,821
-3.96%
3,161,2140.00%2.52%
0.05%
EXELIXIS INCNew $77,9204,524,9612.46%
WAVE LIFE SCIENCES LTD$72,854
16.91%
7,775,2070.00%2.30%
21.78%
ADVERUM BIOTECHNOLOGIES INCNew $71,0547,272,7142.24%
MOMENTA PHARMACEUTICALS INC$68,855
141.38%
2,531,445
75.09%
2.18%
151.44%
BLACK DIAMOND THERAPEUTICS INCNew $64,6182,589,9042.04%
RETROPHIN INC$60,789
0.67%
4,166,453
-2.02%
1.92%
4.87%
ORCHARD THERAPEUTICS PLCads$57,048
-35.07%
10,364,658
62.20%
1.80%
-32.36%
IGM BIOSCIENCES INC$55,180
47.14%
982,7230.00%1.74%
53.28%
VERASTEM INCNew $49,11618,604,6511.55%
RELMADA THERAPEUTICS INC$47,071
58.46%
1,379,988
81.18%
1.49%
65.07%
GILEAD SCIENCES INCNew $40,968548,0001.29%
PREVAIL THERAPEUTICS INC$39,502
-25.81%
3,240,534
-3.66%
1.25%
-22.72%
ARDELYX INC$36,479
-9.30%
6,416,684
19.74%
1.15%
-5.52%
ARCUTIS BIOTHERAPEUTICS INCNew $34,7221,165,1841.10%
ADAPTIMMUNE THERAPEUTICS PLCsponds adrNew $34,11412,541,8881.08%
CRINETICS PHARMACEUTICALS INC$28,830
-38.72%
1,961,209
4.59%
0.91%
-36.17%
SCPHARMACEUTICALS INC$26,041
41.70%
3,518,998
8.38%
0.82%
47.60%
TRILLIUM THERAPEUTICS INCNew $25,7006,361,4460.81%
STOKE THERAPEUTICS INC$25,647
-19.14%
1,119,9630.00%0.81%
-15.77%
IMARA INCNew $23,3131,454,3480.74%
COMPUGEN LTDordNew $21,4712,957,4340.68%
IMMUNOGEN INCNew $17,6175,166,3030.56%
NOVOCURE LTDNew $17,448259,0990.55%
CONCERT PHARMACEUTICALS INCNew $16,4291,858,4740.52%
SOLID BIOSCIENCES INC$10,925
-46.29%
4,571,1640.00%0.35%
-44.05%
GALERA THERAPEUTICS INC$8,485
-38.84%
893,115
-15.28%
0.27%
-36.29%
X4 PHARMACEUTICALS INC$6,023
108.26%
602,274
122.82%
0.19%
116.95%
PASSAGE BIO INCNew $5,081322,6300.16%
UNIQURE NVNew $3,89982,1800.12%
ESSA PHARMA INC$3,837
-30.24%
959,300
-4.07%
0.12%
-27.33%
PORTOLA PHARMACEUTICALS INC$3,062
-70.14%
429,3990.00%0.10%
-68.89%
SELECTA BIOSCIENCES INCNew $2,098870,6330.07%
INSMED INCNew $1,40187,4050.04%
VERICEL CORPNew $917100,0000.03%
AUDENTES THERAPEUTICS INCSold $0-902,383-1.64%
DYNAVAX TECHNOLOGIES CORPSold $0-2,365,912-0.41%
FORTY SEVEN INCSold $0-1,933,250-2.31%
SYNTHORX INCSold $0-9,724,598-20.61%
Portfolio Information
QuarterQ1 2020
Total value$3,165,729,000
Holdings48
Managers
Peter Kolchinsky
Quarters
2020-03-31
$3,165,729
2019-12-31
$3,297,714
2019-09-30
$1,678,386
2019-06-30
$1,862,830
2019-03-31
$2,319,025
2018-12-31
$1,717,985
2018-09-30
$1,870,521
2018-06-30
$1,540,247
2018-03-31
$1,305,208
2017-12-31
$1,195,149
2017-09-30
$1,106,912
2017-06-30
$871,430
2017-03-31
$815,257
2016-12-31
$705,844
2016-09-30
$969,369
2016-06-30
$722,235
2016-03-31
$782,348
2015-12-31
$1,010,538
2015-09-30
$696,301
2015-06-30
$994,105
2015-03-31
$1,006,949
2014-12-31
$930,497
2014-09-30
$846,275
2014-06-30
$989,267
2014-03-31
$1,394,409
2013-12-31
$858,468
2013-09-30
$958,088
2013-06-30
$753,991
SEC Filings